Differential sensitivity of children and adults to chemical toxicity. I. Biological basis

Robert Scheuplein1, Gail Charnley, Michael Dourson

  • 1Keller and Heckman, Stafford, Virginia 22554, USA.

Insights

Infants under 6 months are often more sensitive to chemical toxicity due to immature metabolic systems. By age 1, children

Area of Science:

  • Pediatric toxicology
  • Developmental biology
  • Environmental health

Background:

  • Children, especially neonates, exhibit higher biological sensitivity to toxicants per body weight compared to adults.
  • Infants up to 6 months possess immature metabolic and physiological systems, leading to prolonged higher blood toxicant levels.

Purpose of the Study:

  • To evaluate the age-dependent sensitivity of children to chemical toxicity.
  • To understand the maturation of metabolic detoxification systems in infants and children.

Main Methods:

  • Review of existing literature on pharmaceuticals, drugs of abuse, environmental contaminants, and dietary agents.
  • Analysis of case examples illustrating toxicant exposure in infants and children.
  • Comparison of metabolic capacities and elimination rates between neonates, infants, and adults.

Main Results:

  • Newborns have low, immature metabolic capacity for many substances, with unique pathways for some chemicals.
  • Metabolic systems mature rapidly, with children generally not more sensitive than adults by 6 months of age.
  • By 1 year, most metabolic systems are nearly fully capable, and children may be less sensitive than adults.

Conclusions:

  • Infant sensitivity to chemical toxicity is primarily due to immature biotransformation and elimination processes.
  • Risk from chemical exposure depends on both inherent sensitivity and exposure levels, with developing children potentially at higher risk.
  • Adequate detoxification capacity protects children from toxicity, irrespective of age, if exposure levels are sufficiently low.

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...